Nurix Therapeutics, Inc. (NRIX)
26.21
-0.66
(-2.47%)
USD |
NASDAQ |
Aug 28, 16:00
26.19
-0.02
(-0.08%)
After-Hours: 20:00
Nurix Therapeutics 30-Day Average Daily Volume : 1.075M for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.075M |
| August 27, 2026 | 1.070M |
| August 26, 2026 | 1.057M |
| August 25, 2026 | 1.075M |
| August 24, 2026 | 1.088M |
| August 21, 2026 | 1.111M |
| August 20, 2026 | 1.113M |
| August 19, 2026 | 1.121M |
| August 18, 2026 | 1.098M |
| August 17, 2026 | 1.112M |
| August 14, 2026 | 1.099M |
| August 13, 2026 | 1.122M |
| August 12, 2026 | 1.116M |
| August 11, 2026 | 1.157M |
| August 10, 2026 | 1.225M |
| August 07, 2026 | 1.412M |
| August 06, 2026 | 1.588M |
| August 05, 2026 | 1.633M |
| August 04, 2026 | 1.653M |
| August 03, 2026 | 1.687M |
| July 31, 2026 | 1.783M |
| July 30, 2026 | 1.842M |
| July 29, 2026 | 1.889M |
| July 28, 2026 | 1.940M |
| July 27, 2026 | 1.987M |
| Date | Value |
|---|---|
| July 24, 2026 | 2.079M |
| July 23, 2026 | 2.135M |
| July 22, 2026 | 2.325M |
| July 21, 2026 | 2.990M |
| July 20, 2026 | 3.012M |
| July 17, 2026 | 3.023M |
| July 16, 2026 | 3.041M |
| July 15, 2026 | 3.047M |
| July 14, 2026 | 3.039M |
| July 13, 2026 | 3.025M |
| July 10, 2026 | 3.003M |
| July 09, 2026 | 2.978M |
| July 08, 2026 | 2.968M |
| July 07, 2026 | 2.956M |
| July 06, 2026 | 2.980M |
| July 02, 2026 | 3.011M |
| July 01, 2026 | 2.999M |
| June 30, 2026 | 3.032M |
| June 29, 2026 | 2.994M |
| June 26, 2026 | 2.920M |
| June 25, 2026 | 2.736M |
| June 24, 2026 | 2.557M |
| June 23, 2026 | 2.508M |
| June 22, 2026 | 2.486M |
| June 18, 2026 | 2.435M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Monte Rosa Therapeutics, Inc. | 1.353M |
| Gilead Sciences, Inc. | 6.292M |
| TG Therapeutics, Inc. | 2.156M |
| Cue Biopharma, Inc. | 195527.5 |
| Keros Therapeutics, Inc. | 203073.7 |